The global microRNA market size was estimated at USD 1.76 billion in 2024 and is projected to reach USD 5.48 billion by 2033, growing at a CAGR of 13.64% from 2025 to 2033. The increasing prevalence of diseases such as cancer, cardiovascular diseases, and neurological disorders across the globe, as well as growing advancements in genomic technologies, are the prime factors that drive market growth. ![MicroRNA Market]( "MicroRNA Market")
This product will be delivered within 2 business days.
Global MicroRNA Market Report Segmentation
This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For the purpose of this report, the analyst has segmented the global microRNA market on the basis of product & service, application, end-use, and region:- Product & Services Outlook (Revenue in USD Million, 2021-2033)
- Services
- Products
Application Outlook (Revenue, USD Million, 2021-2033)
- Cancer
- Infectious Diseases
- Immunological Disorder
- Cardiovascular Disease
- Neurological Disease
- Others
End-use Outlook (Revenue, USD Million; 2021-2033)
- Biotechnology & Pharmaceutical Companies
- Academic & Government Research Institutes
- Others
Regional Outlook (Revenue, USD Million, 2021-2033)
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listings for you to stay ahead of the curve
This product will be delivered within 2 business days.
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Segment Definitions
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Objective
1.4.1. Objective 1
1.4.2. Objective2
1.4.3. Objective 3
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. Internal Database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information or Data Analysis:
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.10. List of Secondary Sources
1.11. List of Abbreviations
1.1.1. Segment Definitions
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Objective
1.4.1. Objective 1
1.4.2. Objective2
1.4.3. Objective 3
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. Internal Database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information or Data Analysis:
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.10. List of Secondary Sources
1.11. List of Abbreviations
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables and Trends
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Expanding use of miRNA in drug development & therapeutics
3.2.1.2. Increasing cancer prevalence and need for early-stage diagnostics
3.2.2. Market Restraint Analysis
3.2.2.1. High cost associated with microRNA kits and other products
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Expanding use of miRNA in drug development & therapeutics
3.2.1.2. Increasing cancer prevalence and need for early-stage diagnostics
3.2.2. Market Restraint Analysis
3.2.2.1. High cost associated with microRNA kits and other products
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
Chapter 4. Product & Service Business Analysis
4.1. Segment Dashboard
4.2. MicroRNA Market: Product & Service Movement Analysis
4.3. Product
4.3.1. Product Market Estimates and Forecasts, 2021-2033 (USD Million)
4.3.2. Instruments
4.3.2.1. Instruments Market Estimates and Forecasts, 2021-2033 (USD Million)
4.3.2.2. By Technology
4.3.2.2.1. Real-Time PCR
4.3.2.2.1.1. Real-Time PCR Market Estimates and Forecasts, 2021-2033 (USD Million)
4.3.2.2.2. Microarray
4.3.2.2.2.1. Microarray Market Estimates and Forecasts, 2021-2033 (USD Million)
4.3.2.2.3. NGS
4.3.2.2.3.1. NGS Market Estimates and Forecasts, 2021-2033 (USD Million)
4.3.2.2.4. Others
4.3.2.2.4.1. Others Market Estimates and Forecasts, 2021-2033 (USD Million)
4.3.2.3. By Workflow
4.3.2.3.1. Isolation & Purification
4.3.2.3.1.1. Isolation & Purification Market Estimates and Forecasts, 2021-2033 (USD Million)
4.3.2.3.2. miRNA cDNA Synthesis
4.3.2.3.2.1. miRNA cDNA Synthesis Market Estimates and Forecasts, 2021-2033 (USD Million)
4.3.2.3.3. Profiling, Localization, & Qualification
4.3.2.3.3.1. Profiling, Localization, & Qualification Market Estimates and Forecasts, 2021-2033 (USD Million)
4.3.2.3.4. Functional Analysis & Others
4.3.2.3.4.1. Functional Analysis & Others Market Estimates and Forecasts, 2021-2033 (USD Million)
4.3.2.3.5. Others
4.3.2.3.5.1. Others Market Estimates and Forecasts, 2021-2033 (USD Million)
4.3.3. Consumables
4.3.3.1. Consumables Market Estimates and Forecasts, 2021-2033 (USD Million)
4.3.3.2. By Specimen
4.3.3.2.1. Whole Blood
4.3.3.2.1.1. Whole Blood Market Estimates and Forecasts, 2021-2033 (USD Million)
4.3.3.2.2. Serum
4.3.3.2.2.1. Serum Market Estimates and Forecasts, 2021-2033 (USD Million)
4.3.3.2.3. Plasma
4.3.3.2.3.1. Plasma Market Estimates and Forecasts, 2021-2033 (USD Million)
4.3.3.2.4. FFPE
4.3.3.2.4.1. FFPE Market Estimates and Forecasts, 2021-2033 (USD Million)
4.3.3.2.5. Fresh Frozen Tissue
4.3.3.2.5.1. Fresh Frozen Tissue Market Estimates and Forecasts, 2021-2033 (USD Million)
4.3.3.2.6. Others
4.3.3.2.6.1. Others Market Estimates and Forecasts, 2021-2033 (USD Million)
4.3.3.3. By Workflow
4.3.3.3.1. Isolation & Purification
4.3.3.3.1.1. Isolation & Purification Market Estimates and Forecasts, 2021-2033 (USD Million)
4.3.3.3.2. miRNA cDNA Synthesis
4.3.3.3.2.1. miRNA cDNA Synthesis Market Estimates and Forecasts, 2021-2033 (USD Million)
4.3.3.3.3. Profiling, Localization, & Qualification
4.3.3.3.3.1. Profiling, Localization, & Qualification Market Estimates and Forecasts, 2021-2033 (USD Million)
4.3.3.3.4. Functional Analysis & Others
4.3.3.3.4.1. Functional Analysis & Others Market Estimates and Forecasts, 2021-2033 (USD Million)
4.3.3.3.5. Others
4.3.3.3.5.1. Others Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4. Services
4.4.1. Services Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.2. By Service Type
4.4.2.1. Isolation & Purification
4.4.2.1.1. Isolation & Purification Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.2.2. miRNA cDNA Synthesis
4.4.2.2.1. miRNA cDNA Synthesis Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.2.3. Profiling, Localization, & Qualification
4.4.2.3.1. Profiling, Localization, & Qualification Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.2.4. Functional Analysis
4.4.2.4.1. Functional Analysis Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.2.5. Others
4.4.2.5.1. Others Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.3. By Specimen
4.4.3.1. Whole Blood
4.4.3.1.1. Whole Blood Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.3.2. Serum
4.4.3.2.1. Serum Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.3.3. Plasma
4.4.3.3.1. Plasma Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.3.4. FFPE
4.4.3.4.1. FFPE Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.3.5. Fresh Frozen Tissue
4.4.3.5.1. Fresh Frozen Tissue Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.3.6. Others
4.4.3.6.1. Others Market Estimates and Forecasts, 2021-2033 (USD Million)
4.2. MicroRNA Market: Product & Service Movement Analysis
4.3. Product
4.3.1. Product Market Estimates and Forecasts, 2021-2033 (USD Million)
4.3.2. Instruments
4.3.2.1. Instruments Market Estimates and Forecasts, 2021-2033 (USD Million)
4.3.2.2. By Technology
4.3.2.2.1. Real-Time PCR
4.3.2.2.1.1. Real-Time PCR Market Estimates and Forecasts, 2021-2033 (USD Million)
4.3.2.2.2. Microarray
4.3.2.2.2.1. Microarray Market Estimates and Forecasts, 2021-2033 (USD Million)
4.3.2.2.3. NGS
4.3.2.2.3.1. NGS Market Estimates and Forecasts, 2021-2033 (USD Million)
4.3.2.2.4. Others
4.3.2.2.4.1. Others Market Estimates and Forecasts, 2021-2033 (USD Million)
4.3.2.3. By Workflow
4.3.2.3.1. Isolation & Purification
4.3.2.3.1.1. Isolation & Purification Market Estimates and Forecasts, 2021-2033 (USD Million)
4.3.2.3.2. miRNA cDNA Synthesis
4.3.2.3.2.1. miRNA cDNA Synthesis Market Estimates and Forecasts, 2021-2033 (USD Million)
4.3.2.3.3. Profiling, Localization, & Qualification
4.3.2.3.3.1. Profiling, Localization, & Qualification Market Estimates and Forecasts, 2021-2033 (USD Million)
4.3.2.3.4. Functional Analysis & Others
4.3.2.3.4.1. Functional Analysis & Others Market Estimates and Forecasts, 2021-2033 (USD Million)
4.3.2.3.5. Others
4.3.2.3.5.1. Others Market Estimates and Forecasts, 2021-2033 (USD Million)
4.3.3. Consumables
4.3.3.1. Consumables Market Estimates and Forecasts, 2021-2033 (USD Million)
4.3.3.2. By Specimen
4.3.3.2.1. Whole Blood
4.3.3.2.1.1. Whole Blood Market Estimates and Forecasts, 2021-2033 (USD Million)
4.3.3.2.2. Serum
4.3.3.2.2.1. Serum Market Estimates and Forecasts, 2021-2033 (USD Million)
4.3.3.2.3. Plasma
4.3.3.2.3.1. Plasma Market Estimates and Forecasts, 2021-2033 (USD Million)
4.3.3.2.4. FFPE
4.3.3.2.4.1. FFPE Market Estimates and Forecasts, 2021-2033 (USD Million)
4.3.3.2.5. Fresh Frozen Tissue
4.3.3.2.5.1. Fresh Frozen Tissue Market Estimates and Forecasts, 2021-2033 (USD Million)
4.3.3.2.6. Others
4.3.3.2.6.1. Others Market Estimates and Forecasts, 2021-2033 (USD Million)
4.3.3.3. By Workflow
4.3.3.3.1. Isolation & Purification
4.3.3.3.1.1. Isolation & Purification Market Estimates and Forecasts, 2021-2033 (USD Million)
4.3.3.3.2. miRNA cDNA Synthesis
4.3.3.3.2.1. miRNA cDNA Synthesis Market Estimates and Forecasts, 2021-2033 (USD Million)
4.3.3.3.3. Profiling, Localization, & Qualification
4.3.3.3.3.1. Profiling, Localization, & Qualification Market Estimates and Forecasts, 2021-2033 (USD Million)
4.3.3.3.4. Functional Analysis & Others
4.3.3.3.4.1. Functional Analysis & Others Market Estimates and Forecasts, 2021-2033 (USD Million)
4.3.3.3.5. Others
4.3.3.3.5.1. Others Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4. Services
4.4.1. Services Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.2. By Service Type
4.4.2.1. Isolation & Purification
4.4.2.1.1. Isolation & Purification Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.2.2. miRNA cDNA Synthesis
4.4.2.2.1. miRNA cDNA Synthesis Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.2.3. Profiling, Localization, & Qualification
4.4.2.3.1. Profiling, Localization, & Qualification Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.2.4. Functional Analysis
4.4.2.4.1. Functional Analysis Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.2.5. Others
4.4.2.5.1. Others Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.3. By Specimen
4.4.3.1. Whole Blood
4.4.3.1.1. Whole Blood Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.3.2. Serum
4.4.3.2.1. Serum Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.3.3. Plasma
4.4.3.3.1. Plasma Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.3.4. FFPE
4.4.3.4.1. FFPE Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.3.5. Fresh Frozen Tissue
4.4.3.5.1. Fresh Frozen Tissue Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.3.6. Others
4.4.3.6.1. Others Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 5. Application Business Analysis
5.1. Segment Dashboard
5.2. MicroRNA Market: Application Movement Analysis
5.3. Cancer
5.3.1. Cancer Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.4. Infectious Diseases
5.4.1. Infectious Diseases Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.5. Immunological Disorder
5.5.1. Immunological Disorder Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.6. Cardiovascular Disease
5.6.1. Cardiovascular Disease Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.7. Neurological Disease
5.7.1. Neurological Disease Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.8. Others
5.8.1. Others Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.2. MicroRNA Market: Application Movement Analysis
5.3. Cancer
5.3.1. Cancer Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.4. Infectious Diseases
5.4.1. Infectious Diseases Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.5. Immunological Disorder
5.5.1. Immunological Disorder Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.6. Cardiovascular Disease
5.6.1. Cardiovascular Disease Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.7. Neurological Disease
5.7.1. Neurological Disease Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.8. Others
5.8.1. Others Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 6. End Use Business Analysis
6.1. Segment Dashboard
6.2. MicroRNA Market: End Use Movement Analysis
6.3. Biotechnology & Pharmaceutical Companies
6.3.1. Biotechnology & Pharmaceutical Companies Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
6.4. Academic & Government Research Institutes
6.4.1. Academic & Government Research Institutes Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
6.5. Other End-users
6.5.1. Other End-users Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
6.2. MicroRNA Market: End Use Movement Analysis
6.3. Biotechnology & Pharmaceutical Companies
6.3.1. Biotechnology & Pharmaceutical Companies Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
6.4. Academic & Government Research Institutes
6.4.1. Academic & Government Research Institutes Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
6.5. Other End-users
6.5.1. Other End-users Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 7. Regional Business Analysis
7.1. MicroRNA Market Share By Region, 2024 & 2033
7.2. North America
7.2.1. North America MicroRNA Market, 2021-2033 (USD Million)
7.2.2. U.S.
7.2.2.1. Key Country Dynamics
7.2.2.2. Regulatory framework
7.2.2.3. Competitive Scenario
7.2.2.4. U.S. MicroRNA Market, 2021-2033 (USD Million)
7.2.3. Canada
7.2.3.1. Key Country Dynamics
7.2.3.2. Regulatory framework
7.2.3.3. Competitive Scenario
7.2.3.4. Canada MicroRNA Market, 2021-2033 (USD Million)
7.2.4. Mexico
7.2.4.1. Key Country Dynamics
7.2.4.2. Regulatory framework
7.2.4.3. Competitive Scenario
7.2.4.4. Mexico MicroRNA Market, 2021-2033 (USD Million)
7.3. Europe
7.3.1. Europe MicroRNA Market, 2021-2033 (USD Million)
7.3.2. UK
7.3.2.1. Key Country Dynamics
7.3.2.2. Regulatory framework
7.3.2.3. Competitive Scenario
7.3.2.4. UK MicroRNA Market, 2021-2033 (USD Million)
7.3.3. Germany
7.3.3.1. Key Country Dynamics
7.3.3.2. Regulatory framework
7.3.3.3. Competitive Scenario
7.3.3.4. Germany MicroRNA Market, 2021-2033 (USD Million)
7.3.4. France
7.3.4.1. Key Country Dynamics
7.3.4.2. Regulatory framework
7.3.4.3. Competitive Scenario
7.3.4.4. France MicroRNA Market, 2021-2033 (USD Million)
7.3.5. Italy
7.3.5.1. Key Country Dynamics
7.3.5.2. Regulatory framework
7.3.5.3. Competitive Scenario
7.3.5.4. Italy MicroRNA Market, 2021-2033 (USD Million)
7.3.6. Spain
7.3.6.1. Key Country Dynamics
7.3.6.2. Regulatory framework
7.3.6.3. Competitive Scenario
7.3.6.4. Spain MicroRNA Market, 2021-2033 (USD Million)
7.3.7. Denmark
7.3.7.1. Key Country Dynamics
7.3.7.2. Regulatory framework
7.3.7.3. Competitive Scenario
7.3.7.4. Denmark MicroRNA Market, 2021-2033 (USD Million)
7.3.8. Sweden
7.3.8.1. Key Country Dynamics
7.3.8.2. Regulatory framework
7.3.8.3. Competitive Scenario
7.3.8.4. Sweden MicroRNA Market, 2021-2033 (USD Million)
7.3.9. Norway
7.3.9.1. Key Country Dynamics
7.3.9.2. Regulatory framework
7.3.9.3. Competitive Scenario
7.3.9.4. Norway MicroRNA Market, 2021-2033 (USD Million)
7.4. Asia-Pacific
7.4.1. Asia-Pacific MicroRNA Market, 2021-2033 (USD Million)
7.4.2. Japan
7.4.2.1. Key Country Dynamics
7.4.2.2. Regulatory framework
7.4.2.3. Competitive Scenario
7.4.2.4. Japan MicroRNA Market, 2021-2033 (USD Million)
7.4.3. China
7.4.3.1. Key Country Dynamics
7.4.3.2. Regulatory framework
7.4.3.3. Competitive Scenario
7.4.3.4. China MicroRNA Market, 2021-2033 (USD Million)
7.4.4. India
7.4.4.1. Key Country Dynamics
7.4.4.2. Regulatory framework
7.4.4.3. Competitive Scenario
7.4.4.4. India MicroRNA Market, 2021-2033 (USD Million)
7.4.5. Australia
7.4.5.1. Key Country Dynamics
7.4.5.2. Regulatory framework
7.4.5.3. Competitive Scenario
7.4.5.4. Australia MicroRNA Market, 2021-2033 (USD Million)
7.4.6. Thailand
7.4.6.1. Key Country Dynamics
7.4.6.2. Regulatory framework
7.4.6.3. Competitive Scenario
7.4.6.4. Thailand MicroRNA Market, 2021-2033 (USD Million)
7.4.7. South Korea
7.4.7.1. Key Country Dynamics
7.4.7.2. Regulatory framework
7.4.7.3. Competitive Scenario
7.4.7.4. South Korea MicroRNA Market, 2021-2033 (USD Million)
7.5. Latin America
7.5.1. Latin America MicroRNA Market, 2021-2033 (USD Million)
7.5.2. Brazil
7.5.2.1. Key Country Dynamics
7.5.2.2. Regulatory framework
7.5.2.3. Competitive Scenario
7.5.2.4. Brazil MicroRNA Market, 2021-2033 (USD Million)
7.5.3. Argentina
7.5.3.1. Key Country Dynamics
7.5.3.2. Regulatory framework
7.5.3.3. Competitive Scenario
7.5.3.4. Argentina MicroRNA Market, 2021-2033 (USD Million)
7.6. MEA
7.6.1. MEA MicroRNA Market, 2021-2033 (USD Million)
7.6.2. South Africa
7.6.2.1. Key Country Dynamics
7.6.2.2. Regulatory framework
7.6.2.3. Competitive Scenario
7.6.2.4. South Africa MicroRNA Market, 2021-2033 (USD Million)
7.6.3. Saudi Arabia
7.6.3.1. Key Country Dynamics
7.6.3.2. Regulatory framework
7.6.3.3. Competitive Scenario
7.6.3.4. Saudi Arabia MicroRNA Market, 2021-2033 (USD Million)
7.6.4. UAE
7.6.4.1. Key Country Dynamics
7.6.4.2. Regulatory framework
7.6.4.3. Competitive Scenario
7.6.4.4. UAE MicroRNA Market, 2021-2033 (USD Million)
7.6.5. Kuwait
7.6.5.1. Key Country Dynamics
7.6.5.2. Regulatory framework
7.6.5.3. Competitive Scenario
7.6.5.4. Kuwait MicroRNA Market, 2021-2033 (USD Million)
7.2. North America
7.2.1. North America MicroRNA Market, 2021-2033 (USD Million)
7.2.2. U.S.
7.2.2.1. Key Country Dynamics
7.2.2.2. Regulatory framework
7.2.2.3. Competitive Scenario
7.2.2.4. U.S. MicroRNA Market, 2021-2033 (USD Million)
7.2.3. Canada
7.2.3.1. Key Country Dynamics
7.2.3.2. Regulatory framework
7.2.3.3. Competitive Scenario
7.2.3.4. Canada MicroRNA Market, 2021-2033 (USD Million)
7.2.4. Mexico
7.2.4.1. Key Country Dynamics
7.2.4.2. Regulatory framework
7.2.4.3. Competitive Scenario
7.2.4.4. Mexico MicroRNA Market, 2021-2033 (USD Million)
7.3. Europe
7.3.1. Europe MicroRNA Market, 2021-2033 (USD Million)
7.3.2. UK
7.3.2.1. Key Country Dynamics
7.3.2.2. Regulatory framework
7.3.2.3. Competitive Scenario
7.3.2.4. UK MicroRNA Market, 2021-2033 (USD Million)
7.3.3. Germany
7.3.3.1. Key Country Dynamics
7.3.3.2. Regulatory framework
7.3.3.3. Competitive Scenario
7.3.3.4. Germany MicroRNA Market, 2021-2033 (USD Million)
7.3.4. France
7.3.4.1. Key Country Dynamics
7.3.4.2. Regulatory framework
7.3.4.3. Competitive Scenario
7.3.4.4. France MicroRNA Market, 2021-2033 (USD Million)
7.3.5. Italy
7.3.5.1. Key Country Dynamics
7.3.5.2. Regulatory framework
7.3.5.3. Competitive Scenario
7.3.5.4. Italy MicroRNA Market, 2021-2033 (USD Million)
7.3.6. Spain
7.3.6.1. Key Country Dynamics
7.3.6.2. Regulatory framework
7.3.6.3. Competitive Scenario
7.3.6.4. Spain MicroRNA Market, 2021-2033 (USD Million)
7.3.7. Denmark
7.3.7.1. Key Country Dynamics
7.3.7.2. Regulatory framework
7.3.7.3. Competitive Scenario
7.3.7.4. Denmark MicroRNA Market, 2021-2033 (USD Million)
7.3.8. Sweden
7.3.8.1. Key Country Dynamics
7.3.8.2. Regulatory framework
7.3.8.3. Competitive Scenario
7.3.8.4. Sweden MicroRNA Market, 2021-2033 (USD Million)
7.3.9. Norway
7.3.9.1. Key Country Dynamics
7.3.9.2. Regulatory framework
7.3.9.3. Competitive Scenario
7.3.9.4. Norway MicroRNA Market, 2021-2033 (USD Million)
7.4. Asia-Pacific
7.4.1. Asia-Pacific MicroRNA Market, 2021-2033 (USD Million)
7.4.2. Japan
7.4.2.1. Key Country Dynamics
7.4.2.2. Regulatory framework
7.4.2.3. Competitive Scenario
7.4.2.4. Japan MicroRNA Market, 2021-2033 (USD Million)
7.4.3. China
7.4.3.1. Key Country Dynamics
7.4.3.2. Regulatory framework
7.4.3.3. Competitive Scenario
7.4.3.4. China MicroRNA Market, 2021-2033 (USD Million)
7.4.4. India
7.4.4.1. Key Country Dynamics
7.4.4.2. Regulatory framework
7.4.4.3. Competitive Scenario
7.4.4.4. India MicroRNA Market, 2021-2033 (USD Million)
7.4.5. Australia
7.4.5.1. Key Country Dynamics
7.4.5.2. Regulatory framework
7.4.5.3. Competitive Scenario
7.4.5.4. Australia MicroRNA Market, 2021-2033 (USD Million)
7.4.6. Thailand
7.4.6.1. Key Country Dynamics
7.4.6.2. Regulatory framework
7.4.6.3. Competitive Scenario
7.4.6.4. Thailand MicroRNA Market, 2021-2033 (USD Million)
7.4.7. South Korea
7.4.7.1. Key Country Dynamics
7.4.7.2. Regulatory framework
7.4.7.3. Competitive Scenario
7.4.7.4. South Korea MicroRNA Market, 2021-2033 (USD Million)
7.5. Latin America
7.5.1. Latin America MicroRNA Market, 2021-2033 (USD Million)
7.5.2. Brazil
7.5.2.1. Key Country Dynamics
7.5.2.2. Regulatory framework
7.5.2.3. Competitive Scenario
7.5.2.4. Brazil MicroRNA Market, 2021-2033 (USD Million)
7.5.3. Argentina
7.5.3.1. Key Country Dynamics
7.5.3.2. Regulatory framework
7.5.3.3. Competitive Scenario
7.5.3.4. Argentina MicroRNA Market, 2021-2033 (USD Million)
7.6. MEA
7.6.1. MEA MicroRNA Market, 2021-2033 (USD Million)
7.6.2. South Africa
7.6.2.1. Key Country Dynamics
7.6.2.2. Regulatory framework
7.6.2.3. Competitive Scenario
7.6.2.4. South Africa MicroRNA Market, 2021-2033 (USD Million)
7.6.3. Saudi Arabia
7.6.3.1. Key Country Dynamics
7.6.3.2. Regulatory framework
7.6.3.3. Competitive Scenario
7.6.3.4. Saudi Arabia MicroRNA Market, 2021-2033 (USD Million)
7.6.4. UAE
7.6.4.1. Key Country Dynamics
7.6.4.2. Regulatory framework
7.6.4.3. Competitive Scenario
7.6.4.4. UAE MicroRNA Market, 2021-2033 (USD Million)
7.6.5. Kuwait
7.6.5.1. Key Country Dynamics
7.6.5.2. Regulatory framework
7.6.5.3. Competitive Scenario
7.6.5.4. Kuwait MicroRNA Market, 2021-2033 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Strategy Mapping
8.3. Company Market Position Analysis, 2024
8.4. Company Profiles/Listing
8.4.1. Thermo Fisher Scientific
8.4.1.1. Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. QIAGEN
8.4.2.1. Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. Horizon Discovery Group plc.
8.4.3.1. Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. Merck KGaA
8.4.4.1. Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. Takara Bio, Inc.
8.4.5.1. Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. LGC Limited
8.4.6.1. Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. BioGenex
8.4.7.1. Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. GeneCopoeia, Inc.
8.4.8.1. Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Strategic Initiatives
8.4.9. New England Biolabs
8.4.9.1. Overview
8.4.9.2. Financial Performance
8.4.9.3. Product Benchmarking
8.4.9.4. Strategic Initiatives
8.4.10. NanoString Technologies, Inc.
8.4.10.1. Overview
8.4.10.2. Financial Performance
8.4.10.3. Product Benchmarking
8.4.10.4. Strategic Initiatives
8.2. Strategy Mapping
8.3. Company Market Position Analysis, 2024
8.4. Company Profiles/Listing
8.4.1. Thermo Fisher Scientific
8.4.1.1. Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. QIAGEN
8.4.2.1. Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. Horizon Discovery Group plc.
8.4.3.1. Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. Merck KGaA
8.4.4.1. Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. Takara Bio, Inc.
8.4.5.1. Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. LGC Limited
8.4.6.1. Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. BioGenex
8.4.7.1. Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. GeneCopoeia, Inc.
8.4.8.1. Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Strategic Initiatives
8.4.9. New England Biolabs
8.4.9.1. Overview
8.4.9.2. Financial Performance
8.4.9.3. Product Benchmarking
8.4.9.4. Strategic Initiatives
8.4.10. NanoString Technologies, Inc.
8.4.10.1. Overview
8.4.10.2. Financial Performance
8.4.10.3. Product Benchmarking
8.4.10.4. Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global MicroRNA Market, by Product & Services, 2021-2033 (USD Million)
Table 4 Global MicroRNA Market, by Application, 2021-2033 (USD Million)
Table 5 Global MicroRNA Market, End-user, 2021-2033 (USD Million)
Table 6 Global MicroRNA Market, by Region, 2021-2033 (USD Million)
Table 7 North America MicroRNA Market, by Country, 2021-2033 (USD Million)
Table 8 North America MicroRNA Market, by Product & Services, 2021-2033 (USD Million)
Table 9 North America MicroRNA Market, by Application, 2021-2033 (USD Million)
Table 10 North America MicroRNA Market, End-user, 2021-2033 (USD Million)
Table 11 U.S. MicroRNA Market, by Product & Services, 2021-2033 (USD Million)
Table 12 U.S. MicroRNA Market, by Application, 2021-2033 (USD Million)
Table 13 U.S. MicroRNA Market, End-user, 2021-2033 (USD Million)
Table 14 Canada MicroRNA Market, by Product & Services, 2021-2033 (USD Million)
Table 15 Canada MicroRNA Market, by Application, 2021-2033 (USD Million)
Table 16 Canada MicroRNA Market, End-user, 2021-2033 (USD Million)
Table 17 Mexico MicroRNA Market, by Product & Services, 2021-2033 (USD Million)
Table 18 Mexico MicroRNA Market, by Application, 2021-2033 (USD Million)
Table 19 Mexico MicroRNA Market, End-user, 2021-2033 (USD Million)
Table 20 Europe MicroRNA Market, by Country, 2021-2033 (USD Million)
Table 21 Europe MicroRNA Market, by Product & Services, 2021-2033 (USD Million)
Table 22 Europe MicroRNA Market, by Application, 2021-2033 (USD Million)
Table 23 Europe MicroRNA Market, End-user, 2021-2033 (USD Million)
Table 24 Germany MicroRNA Market, by Product & Services, 2021-2033 (USD Million)
Table 25 Germany MicroRNA Market, by Application, 2021-2033 (USD Million)
Table 26 Germany MicroRNA Market, End-user, 2021-2033 (USD Million)
Table 27 UK MicroRNA Market, by Product & Services, 2021-2033 (USD Million)
Table 28 UK MicroRNA Market, by Application, 2021-2033 (USD Million)
Table 29 UK MicroRNA Market, End-user, 2021-2033 (USD Million)
Table 30 France MicroRNA Market, by Product & Services, 2021-2033 (USD Million)
Table 31 France MicroRNA Market, by Application, 2021-2033 (USD Million)
Table 32 France MicroRNA Market, End-user, 2021-2033 (USD Million)
Table 33 Italy MicroRNA Market, by Product & Services, 2021-2033 (USD Million)
Table 34 Italy MicroRNA Market, by Application, 2021-2033 (USD Million)
Table 35 Italy MicroRNA Market, End-user, 2021-2033 (USD Million)
Table 36 Spain MicroRNA Market, by Product & Services, 2021-2033 (USD Million)
Table 37 Spain MicroRNA Market, by Application, 2021-2033 (USD Million)
Table 38 Spain MicroRNA Market, End-user, 2021-2033 (USD Million)
Table 39 Denmark MicroRNA Market, by Product & Services, 2021-2033 (USD Million)
Table 40 Denmark MicroRNA Market, by Application, 2021-2033 (USD Million)
Table 41 Denmark MicroRNA Market, End-user, 2021-2033 (USD Million)
Table 42 Norway MicroRNA Market, by Product & Services, 2021-2033 (USD Million)
Table 43 Norway MicroRNA Market, by Application, 2021-2033 (USD Million)
Table 44 Norway MicroRNA Market, End-user, 2021-2033 (USD Million)
Table 45 Sweden MicroRNA Market, by Product & Services, 2021-2033 (USD Million)
Table 46 Sweden MicroRNA Market, by Application, 2021-2033 (USD Million)
Table 47 Sweden MicroRNA Market, End-user, 2021-2033 (USD Million)
Table 48 Asia-Pacific MicroRNA Market, by Country, 2021-2033 (USD Million)
Table 49 Asia-Pacific MicroRNA Market, End-user, 2021-2033 (USD Million)
Table 50 Asia-Pacific MicroRNA Market, by Product & Services, 2021-2033 (USD Million)
Table 51 Asia-Pacific MicroRNA Market, by Application, 2021-2033 (USD Million)
Table 52 Asia-Pacific MicroRNA Market, End-user, 2021-2033 (USD Million)
Table 53 China MicroRNA Market, by Product & Services, 2021-2033 (USD Million)
Table 54 China MicroRNA Market, by Application, 2021-2033 (USD Million)
Table 55 China MicroRNA Market, End-user, 2021-2033 (USD Million)
Table 56 Japan MicroRNA Market, by Product & Services, 2021-2033 (USD Million)
Table 57 Japan MicroRNA Market, by Application, 2021-2033 (USD Million)
Table 58 Japan MicroRNA Market, End-user, 2021-2033 (USD Million)
Table 59 India MicroRNA Market, by Product & Services, 2021-2033 (USD Million)
Table 60 India MicroRNA Market, by Application, 2021-2033 (USD Million)
Table 61 India MicroRNA Market, End-user, 2021-2033 (USD Million)
Table 62 South Korea MicroRNA Market, by Product & Services, 2021-2033 (USD Million)
Table 63 South Korea MicroRNA Market, by Application, 2021-2033 (USD Million)
Table 64 South Korea MicroRNA Market, End-user, 2021-2033 (USD Million)
Table 65 Australia MicroRNA Market, by Product & Services, 2021-2033 (USD Million)
Table 66 Australia MicroRNA Market, by Application, 2021-2033 (USD Million)
Table 67 Australia MicroRNA Market, End-user, 2021-2033 (USD Million)
Table 68 Thailand MicroRNA Market, by Product & Services, 2021-2033 (USD Million)
Table 69 Thailand MicroRNA Market, by Application, 2021-2033 (USD Million)
Table 70 Thailand MicroRNA Market, End-user, 2021-2033 (USD Million)
Table 71 Latin America MicroRNA Market, by Product & Services, 2021-2033 (USD Million)
Table 72 Latin America MicroRNA Market, by Application, 2021-2033 (USD Million)
Table 73 Latin America MicroRNA Market, End-user, 2021-2033 (USD Million)
Table 74 Brazil MicroRNA Market, by Product & Services, 2021-2033 (USD Million)
Table 75 Brazil MicroRNA Market, by Application, 2021-2033 (USD Million)
Table 76 Brazil MicroRNA Market, End-user, 2021-2033 (USD Million)
Table 77 Argentina MicroRNA Market, by Product & Services, 2021-2033 (USD Million)
Table 78 Argentina MicroRNA Market, by Application, 2021-2033 (USD Million)
Table 79 Argentina MicroRNA Market, End-user, 2021-2033 (USD Million)
Table 80 Middle East & Africa MicroRNA Market, by Country, 2021-2033 (USD Million)
Table 81 Middle East & Africa MicroRNA Market, by Product & Services, 2021-2033 (USD Million)
Table 82 Middle East & Africa MicroRNA Market, by Application, 2021-2033 (USD Million)
Table 83 Middle East & Africa MicroRNA Market, End-user, 2021-2033 (USD Million)
Table 84 South Africa MicroRNA Market, by Product & Services, 2021-2033 (USD Million)
Table 85 South Africa MicroRNA Market, by Application, 2021-2033 (USD Million)
Table 86 South Africa MicroRNA Market, End-user, 2021-2033 (USD Million)
Table 87 Saudi Arabia MicroRNA Market, by Product & Services, 2021-2033 (USD Million)
Table 88 Saudi Arabia MicroRNA Market, by Application, 2021-2033 (USD Million)
Table 89 Saudi Arabia MicroRNA Market, End-user, 2021-2033 (USD Million)
Table 90 UAE MicroRNA Market, by Product & Services, 2021-2033 (USD Million)
Table 91 UAE MicroRNA Market, by Application, 2021-2033 (USD Million)
Table 92 UAE MicroRNA Market, End-user, 2021-2033 (USD Million)
Table 93 Kuwait MicroRNA Market, by Product & Services, 2021-2033 (USD Million)
Table 94 Kuwait MicroRNA Market, by Application, 2021-2033 (USD Million)
Table 95 Kuwait MicroRNA Market, End-user, 2021-2033 (USD Million)
Table 2 List of Abbreviations
Table 3 Global MicroRNA Market, by Product & Services, 2021-2033 (USD Million)
Table 4 Global MicroRNA Market, by Application, 2021-2033 (USD Million)
Table 5 Global MicroRNA Market, End-user, 2021-2033 (USD Million)
Table 6 Global MicroRNA Market, by Region, 2021-2033 (USD Million)
Table 7 North America MicroRNA Market, by Country, 2021-2033 (USD Million)
Table 8 North America MicroRNA Market, by Product & Services, 2021-2033 (USD Million)
Table 9 North America MicroRNA Market, by Application, 2021-2033 (USD Million)
Table 10 North America MicroRNA Market, End-user, 2021-2033 (USD Million)
Table 11 U.S. MicroRNA Market, by Product & Services, 2021-2033 (USD Million)
Table 12 U.S. MicroRNA Market, by Application, 2021-2033 (USD Million)
Table 13 U.S. MicroRNA Market, End-user, 2021-2033 (USD Million)
Table 14 Canada MicroRNA Market, by Product & Services, 2021-2033 (USD Million)
Table 15 Canada MicroRNA Market, by Application, 2021-2033 (USD Million)
Table 16 Canada MicroRNA Market, End-user, 2021-2033 (USD Million)
Table 17 Mexico MicroRNA Market, by Product & Services, 2021-2033 (USD Million)
Table 18 Mexico MicroRNA Market, by Application, 2021-2033 (USD Million)
Table 19 Mexico MicroRNA Market, End-user, 2021-2033 (USD Million)
Table 20 Europe MicroRNA Market, by Country, 2021-2033 (USD Million)
Table 21 Europe MicroRNA Market, by Product & Services, 2021-2033 (USD Million)
Table 22 Europe MicroRNA Market, by Application, 2021-2033 (USD Million)
Table 23 Europe MicroRNA Market, End-user, 2021-2033 (USD Million)
Table 24 Germany MicroRNA Market, by Product & Services, 2021-2033 (USD Million)
Table 25 Germany MicroRNA Market, by Application, 2021-2033 (USD Million)
Table 26 Germany MicroRNA Market, End-user, 2021-2033 (USD Million)
Table 27 UK MicroRNA Market, by Product & Services, 2021-2033 (USD Million)
Table 28 UK MicroRNA Market, by Application, 2021-2033 (USD Million)
Table 29 UK MicroRNA Market, End-user, 2021-2033 (USD Million)
Table 30 France MicroRNA Market, by Product & Services, 2021-2033 (USD Million)
Table 31 France MicroRNA Market, by Application, 2021-2033 (USD Million)
Table 32 France MicroRNA Market, End-user, 2021-2033 (USD Million)
Table 33 Italy MicroRNA Market, by Product & Services, 2021-2033 (USD Million)
Table 34 Italy MicroRNA Market, by Application, 2021-2033 (USD Million)
Table 35 Italy MicroRNA Market, End-user, 2021-2033 (USD Million)
Table 36 Spain MicroRNA Market, by Product & Services, 2021-2033 (USD Million)
Table 37 Spain MicroRNA Market, by Application, 2021-2033 (USD Million)
Table 38 Spain MicroRNA Market, End-user, 2021-2033 (USD Million)
Table 39 Denmark MicroRNA Market, by Product & Services, 2021-2033 (USD Million)
Table 40 Denmark MicroRNA Market, by Application, 2021-2033 (USD Million)
Table 41 Denmark MicroRNA Market, End-user, 2021-2033 (USD Million)
Table 42 Norway MicroRNA Market, by Product & Services, 2021-2033 (USD Million)
Table 43 Norway MicroRNA Market, by Application, 2021-2033 (USD Million)
Table 44 Norway MicroRNA Market, End-user, 2021-2033 (USD Million)
Table 45 Sweden MicroRNA Market, by Product & Services, 2021-2033 (USD Million)
Table 46 Sweden MicroRNA Market, by Application, 2021-2033 (USD Million)
Table 47 Sweden MicroRNA Market, End-user, 2021-2033 (USD Million)
Table 48 Asia-Pacific MicroRNA Market, by Country, 2021-2033 (USD Million)
Table 49 Asia-Pacific MicroRNA Market, End-user, 2021-2033 (USD Million)
Table 50 Asia-Pacific MicroRNA Market, by Product & Services, 2021-2033 (USD Million)
Table 51 Asia-Pacific MicroRNA Market, by Application, 2021-2033 (USD Million)
Table 52 Asia-Pacific MicroRNA Market, End-user, 2021-2033 (USD Million)
Table 53 China MicroRNA Market, by Product & Services, 2021-2033 (USD Million)
Table 54 China MicroRNA Market, by Application, 2021-2033 (USD Million)
Table 55 China MicroRNA Market, End-user, 2021-2033 (USD Million)
Table 56 Japan MicroRNA Market, by Product & Services, 2021-2033 (USD Million)
Table 57 Japan MicroRNA Market, by Application, 2021-2033 (USD Million)
Table 58 Japan MicroRNA Market, End-user, 2021-2033 (USD Million)
Table 59 India MicroRNA Market, by Product & Services, 2021-2033 (USD Million)
Table 60 India MicroRNA Market, by Application, 2021-2033 (USD Million)
Table 61 India MicroRNA Market, End-user, 2021-2033 (USD Million)
Table 62 South Korea MicroRNA Market, by Product & Services, 2021-2033 (USD Million)
Table 63 South Korea MicroRNA Market, by Application, 2021-2033 (USD Million)
Table 64 South Korea MicroRNA Market, End-user, 2021-2033 (USD Million)
Table 65 Australia MicroRNA Market, by Product & Services, 2021-2033 (USD Million)
Table 66 Australia MicroRNA Market, by Application, 2021-2033 (USD Million)
Table 67 Australia MicroRNA Market, End-user, 2021-2033 (USD Million)
Table 68 Thailand MicroRNA Market, by Product & Services, 2021-2033 (USD Million)
Table 69 Thailand MicroRNA Market, by Application, 2021-2033 (USD Million)
Table 70 Thailand MicroRNA Market, End-user, 2021-2033 (USD Million)
Table 71 Latin America MicroRNA Market, by Product & Services, 2021-2033 (USD Million)
Table 72 Latin America MicroRNA Market, by Application, 2021-2033 (USD Million)
Table 73 Latin America MicroRNA Market, End-user, 2021-2033 (USD Million)
Table 74 Brazil MicroRNA Market, by Product & Services, 2021-2033 (USD Million)
Table 75 Brazil MicroRNA Market, by Application, 2021-2033 (USD Million)
Table 76 Brazil MicroRNA Market, End-user, 2021-2033 (USD Million)
Table 77 Argentina MicroRNA Market, by Product & Services, 2021-2033 (USD Million)
Table 78 Argentina MicroRNA Market, by Application, 2021-2033 (USD Million)
Table 79 Argentina MicroRNA Market, End-user, 2021-2033 (USD Million)
Table 80 Middle East & Africa MicroRNA Market, by Country, 2021-2033 (USD Million)
Table 81 Middle East & Africa MicroRNA Market, by Product & Services, 2021-2033 (USD Million)
Table 82 Middle East & Africa MicroRNA Market, by Application, 2021-2033 (USD Million)
Table 83 Middle East & Africa MicroRNA Market, End-user, 2021-2033 (USD Million)
Table 84 South Africa MicroRNA Market, by Product & Services, 2021-2033 (USD Million)
Table 85 South Africa MicroRNA Market, by Application, 2021-2033 (USD Million)
Table 86 South Africa MicroRNA Market, End-user, 2021-2033 (USD Million)
Table 87 Saudi Arabia MicroRNA Market, by Product & Services, 2021-2033 (USD Million)
Table 88 Saudi Arabia MicroRNA Market, by Application, 2021-2033 (USD Million)
Table 89 Saudi Arabia MicroRNA Market, End-user, 2021-2033 (USD Million)
Table 90 UAE MicroRNA Market, by Product & Services, 2021-2033 (USD Million)
Table 91 UAE MicroRNA Market, by Application, 2021-2033 (USD Million)
Table 92 UAE MicroRNA Market, End-user, 2021-2033 (USD Million)
Table 93 Kuwait MicroRNA Market, by Product & Services, 2021-2033 (USD Million)
Table 94 Kuwait MicroRNA Market, by Application, 2021-2033 (USD Million)
Table 95 Kuwait MicroRNA Market, End-user, 2021-2033 (USD Million)
List of Figures
Figure 1 MicroRNA market segmentation
Figure 2 Data analysis models
Figure 3 Market formulation and validation
Figure 4 Data validating & publishing
Figure 5 Market research process
Figure 6 Information procurement
Figure 7 Primary research
Figure 8 Value-chain-based sizing & forecasting
Figure 9 QFD modelling for market share assessment
Figure 10 Market formulation & validation
Figure 11 Commodity flow analysis
Figure 12 Market outlook
Figure 13 Segment snapshot
Figure 14 Competitive landscape snapshot
Figure 15 Market trends & outlook
Figure 16 PESTEL analysis
Figure 17 Porter’s five forces analysis
Figure 18 MicroRNA market: Product & services outlook & key takeaways
Figure 19 MicroRNA market: Product & services movement analysis
Figure 20 Products Market, 2021-2033 (USD million)
Figure 21 MicroRNA market: by product type
Figure 22 Instruments Market, 2021-2033 (USD million)
Figure 23 MicroRNA market: by technology
Figure 24 Real Time PCR Market, 2021-2033 (USD million)
Figure 25 Microarray Market, 2021-2033 (USD million)
Figure 26 NGS Market, 2021-2033 (USD million)
Figure 27 Others Market, 2021-2033 (USD million)
Figure 28 MicroRNA market: by workflow
Figure 29 Isolation & Purification Market, 2021-2033 (USD million)
Figure 30 miRNA cDNA Synthesis Market, 2021-2033 (USD million)
Figure 31 Profiling, Localization, & Quantification Market, 2021-2033 (USD million)
Figure 32 Functional Analysis & Others Market, 2021-2033 (USD million)
Figure 33 Others Market, 2021-2033 (USD million)
Figure 34 Consumables Market, 2021-2033 (USD million)
Figure 35 MicroRNA market: by specimen
Figure 36 Whole Blood Market, 2021-2033 (USD million)
Figure 37 Serum Market, 2021-2033 (USD million)
Figure 38 Plasma Market, 2021-2033 (USD million)
Figure 39 FFPE Market, 2021-2033 (USD million)
Figure 40 Fresh Frozen Tissue Market, 2021-2033 (USD million)
Figure 41 Others Market, 2021-2033 (USD million)
Figure 42 MicroRNA market: by workflow
Figure 43 Isolation & Purification Market, 2021-2033 (USD million)
Figure 44 miRNA cDNA Synthesis Market, 2021-2033 (USD million)
Figure 45 Profiling, Localization, & Quantification Market, 2021-2033 (USD million)
Figure 46 Functional Analysis Market, 2021-2033 (USD million)
Figure 47 Others Market, 2021-2033 (USD million)
Figure 48 Services Market, 2021-2033 (USD million)
Figure 49 MicroRNA market: by services type
Figure 50 Isolation & Purification Market, 2021-2033 (USD million)
Figure 51 miRNA cDNA Synthesis Market, 2021-2033 (USD million)
Figure 52 Profiling, Localization, & Quantification Market, 2021-2033 (USD million)
Figure 53 Functional Analysis Market, 2021-2033 (USD million)
Figure 54 Others Market, 2021-2033 (USD million)
Figure 55 MicroRNA market: specimen
Figure 56 Whole Blood Market, 2021-2033 (USD million)
Figure 57 Serum Market, 2021-2033 (USD million)
Figure 58 Plasma Market, 2021-2033 (USD million)
Figure 59 FFPE Market, 2021-2033 (USD million)
Figure 60 Fresh Frozen Tissue Market, 2021-2033 (USD million)
Figure 61 Others Market, 2021-2033 (USD million)
Figure 62 MicroRNA market: Application outlook key takeaways
Figure 63 MicroRNA market: Application movement analysis
Figure 64 Cancer Market, 2021-2033 (USD million)
Figure 65 Infectious Diseases Market, 2021-2033 (USD million)
Figure 66 Immunological Disorder Market, 2021-2033 (USD million)
Figure 67 Cardiovascular Disease Market, 2021-2033 (USD million)
Figure 68 Neurological Disease Market, 2021-2033 (USD million)
Figure 69 Others Market, 2021-2033 (USD million)
Figure 70 MicroRNA market: End use outlook key takeaways
Figure 71 MicroRNA market: End use movement analysis
Figure 72 Biotechnology & Pharmaceutical Companies Market, 2021-2033 (USD million)
Figure 73 Academic & Government Research Institutes Market, 2021-2033 (USD million)
Figure 74 Others Market, 2021-2033 (USD million)
Figure 75 Regional outlook
Figure 76 Regional marketplace: Key takeaways
Figure 77 North America microRNA market estimates and forecasts, 2021-2033 (USD million)
Figure 78 Key country dynamics
Figure 79 U S microRNA market estimates and forecasts, 2021-2033 (USD million)
Figure 80 Key country dynamics
Figure 81 Canada microRNA market estimates and forecasts, 2021-2033 (USD million)
Figure 82 Key country dynamics
Figure 83 Mexico microRNA market estimates and forecasts, 2021-2033 (USD million)
Figure 84 Europe microRNA market estimates and forecasts, 2021-2033 (USD million)
Figure 85 Key country dynamics
Figure 86 Germany microRNA market estimates and forecasts, 2021-2033 (USD million)
Figure 87 Key country dynamics
Figure 88 UK microRNA market estimates and forecasts, 2021-2033 (USD million)
Figure 89 Key country dynamics
Figure 90 France microRNA market estimates and forecasts, 2021-2033 (USD million)
Figure 91 Key country dynamics
Figure 92 Italy microRNA market estimates and forecasts, 2021-2033 (USD million)
Figure 93 Key country dynamics
Figure 94 Spain microRNA market estimates and forecasts, 2021-2033 (USD million)
Figure 95 Key country dynamics
Figure 96 Denmark microRNA market estimates and forecasts, 2021-2033 (USD million)
Figure 97 Key country dynamics
Figure 98 Sweden microRNA market estimates and forecasts, 2021-2033 (USD million)
Figure 99 Key country dynamics
Figure 100 Norway microRNA market estimates and forecasts, 2021-2033 (USD million)
Figure 101 Asia-Pacific microRNA market estimates and forecasts, 2021-2033 (USD million)
Figure 102 Key country dynamics
Figure 103 Japan microRNA market estimates and forecasts, 2021-2033 (USD million)
Figure 104 Key country dynamics
Figure 105 China microRNA market estimates and forecasts, 2021-2033 (USD million)
Figure 106 Key country dynamics
Figure 107 India microRNA market estimates and forecasts, 2021-2033 (USD million)
Figure 108 Key country dynamics
Figure 109 Australia microRNA market estimates and forecasts, 2021-2033 (USD million)
Figure 110 Key country dynamics
Figure 111 Thailand microRNA market estimates and forecasts, 2021-2033 (USD million)
Figure 112 Key country dynamics
Figure 113 South Korea microRNA market estimates and forecasts, 2021-2033 (USD million)
Figure 114 Latin America microRNA market estimates and forecasts, 2021-2033 (USD million)
Figure 115 Key country dynamics
Figure 116 Brazil microRNA market estimates and forecasts, 2021-2033 (USD million)
Figure 117 Key country dynamics
Figure 118 Argentina microRNA market estimates and forecasts, 2021-2033 (USD million)
Figure 119 MEA microRNA market estimates and forecasts, 2021-2033 (USD million)
Figure 120 Key country dynamics
Figure 121 South Africa microRNA market estimates and forecasts, 2021-2033 (USD million)
Figure 122 Key country dynamics
Figure 123 Saudi Arabia microRNA market estimates and forecasts, 2021-2033 (USD million)
Figure 124 Key country dynamics
Figure 125 UAE microRNA market estimates and forecasts, 2021-2033 (USD million)
Figure 126 Key country dynamics
Figure 127 Kuwait microRNA market estimates and forecasts, 2021-2033 (USD million)
Figure 2 Data analysis models
Figure 3 Market formulation and validation
Figure 4 Data validating & publishing
Figure 5 Market research process
Figure 6 Information procurement
Figure 7 Primary research
Figure 8 Value-chain-based sizing & forecasting
Figure 9 QFD modelling for market share assessment
Figure 10 Market formulation & validation
Figure 11 Commodity flow analysis
Figure 12 Market outlook
Figure 13 Segment snapshot
Figure 14 Competitive landscape snapshot
Figure 15 Market trends & outlook
Figure 16 PESTEL analysis
Figure 17 Porter’s five forces analysis
Figure 18 MicroRNA market: Product & services outlook & key takeaways
Figure 19 MicroRNA market: Product & services movement analysis
Figure 20 Products Market, 2021-2033 (USD million)
Figure 21 MicroRNA market: by product type
Figure 22 Instruments Market, 2021-2033 (USD million)
Figure 23 MicroRNA market: by technology
Figure 24 Real Time PCR Market, 2021-2033 (USD million)
Figure 25 Microarray Market, 2021-2033 (USD million)
Figure 26 NGS Market, 2021-2033 (USD million)
Figure 27 Others Market, 2021-2033 (USD million)
Figure 28 MicroRNA market: by workflow
Figure 29 Isolation & Purification Market, 2021-2033 (USD million)
Figure 30 miRNA cDNA Synthesis Market, 2021-2033 (USD million)
Figure 31 Profiling, Localization, & Quantification Market, 2021-2033 (USD million)
Figure 32 Functional Analysis & Others Market, 2021-2033 (USD million)
Figure 33 Others Market, 2021-2033 (USD million)
Figure 34 Consumables Market, 2021-2033 (USD million)
Figure 35 MicroRNA market: by specimen
Figure 36 Whole Blood Market, 2021-2033 (USD million)
Figure 37 Serum Market, 2021-2033 (USD million)
Figure 38 Plasma Market, 2021-2033 (USD million)
Figure 39 FFPE Market, 2021-2033 (USD million)
Figure 40 Fresh Frozen Tissue Market, 2021-2033 (USD million)
Figure 41 Others Market, 2021-2033 (USD million)
Figure 42 MicroRNA market: by workflow
Figure 43 Isolation & Purification Market, 2021-2033 (USD million)
Figure 44 miRNA cDNA Synthesis Market, 2021-2033 (USD million)
Figure 45 Profiling, Localization, & Quantification Market, 2021-2033 (USD million)
Figure 46 Functional Analysis Market, 2021-2033 (USD million)
Figure 47 Others Market, 2021-2033 (USD million)
Figure 48 Services Market, 2021-2033 (USD million)
Figure 49 MicroRNA market: by services type
Figure 50 Isolation & Purification Market, 2021-2033 (USD million)
Figure 51 miRNA cDNA Synthesis Market, 2021-2033 (USD million)
Figure 52 Profiling, Localization, & Quantification Market, 2021-2033 (USD million)
Figure 53 Functional Analysis Market, 2021-2033 (USD million)
Figure 54 Others Market, 2021-2033 (USD million)
Figure 55 MicroRNA market: specimen
Figure 56 Whole Blood Market, 2021-2033 (USD million)
Figure 57 Serum Market, 2021-2033 (USD million)
Figure 58 Plasma Market, 2021-2033 (USD million)
Figure 59 FFPE Market, 2021-2033 (USD million)
Figure 60 Fresh Frozen Tissue Market, 2021-2033 (USD million)
Figure 61 Others Market, 2021-2033 (USD million)
Figure 62 MicroRNA market: Application outlook key takeaways
Figure 63 MicroRNA market: Application movement analysis
Figure 64 Cancer Market, 2021-2033 (USD million)
Figure 65 Infectious Diseases Market, 2021-2033 (USD million)
Figure 66 Immunological Disorder Market, 2021-2033 (USD million)
Figure 67 Cardiovascular Disease Market, 2021-2033 (USD million)
Figure 68 Neurological Disease Market, 2021-2033 (USD million)
Figure 69 Others Market, 2021-2033 (USD million)
Figure 70 MicroRNA market: End use outlook key takeaways
Figure 71 MicroRNA market: End use movement analysis
Figure 72 Biotechnology & Pharmaceutical Companies Market, 2021-2033 (USD million)
Figure 73 Academic & Government Research Institutes Market, 2021-2033 (USD million)
Figure 74 Others Market, 2021-2033 (USD million)
Figure 75 Regional outlook
Figure 76 Regional marketplace: Key takeaways
Figure 77 North America microRNA market estimates and forecasts, 2021-2033 (USD million)
Figure 78 Key country dynamics
Figure 79 U S microRNA market estimates and forecasts, 2021-2033 (USD million)
Figure 80 Key country dynamics
Figure 81 Canada microRNA market estimates and forecasts, 2021-2033 (USD million)
Figure 82 Key country dynamics
Figure 83 Mexico microRNA market estimates and forecasts, 2021-2033 (USD million)
Figure 84 Europe microRNA market estimates and forecasts, 2021-2033 (USD million)
Figure 85 Key country dynamics
Figure 86 Germany microRNA market estimates and forecasts, 2021-2033 (USD million)
Figure 87 Key country dynamics
Figure 88 UK microRNA market estimates and forecasts, 2021-2033 (USD million)
Figure 89 Key country dynamics
Figure 90 France microRNA market estimates and forecasts, 2021-2033 (USD million)
Figure 91 Key country dynamics
Figure 92 Italy microRNA market estimates and forecasts, 2021-2033 (USD million)
Figure 93 Key country dynamics
Figure 94 Spain microRNA market estimates and forecasts, 2021-2033 (USD million)
Figure 95 Key country dynamics
Figure 96 Denmark microRNA market estimates and forecasts, 2021-2033 (USD million)
Figure 97 Key country dynamics
Figure 98 Sweden microRNA market estimates and forecasts, 2021-2033 (USD million)
Figure 99 Key country dynamics
Figure 100 Norway microRNA market estimates and forecasts, 2021-2033 (USD million)
Figure 101 Asia-Pacific microRNA market estimates and forecasts, 2021-2033 (USD million)
Figure 102 Key country dynamics
Figure 103 Japan microRNA market estimates and forecasts, 2021-2033 (USD million)
Figure 104 Key country dynamics
Figure 105 China microRNA market estimates and forecasts, 2021-2033 (USD million)
Figure 106 Key country dynamics
Figure 107 India microRNA market estimates and forecasts, 2021-2033 (USD million)
Figure 108 Key country dynamics
Figure 109 Australia microRNA market estimates and forecasts, 2021-2033 (USD million)
Figure 110 Key country dynamics
Figure 111 Thailand microRNA market estimates and forecasts, 2021-2033 (USD million)
Figure 112 Key country dynamics
Figure 113 South Korea microRNA market estimates and forecasts, 2021-2033 (USD million)
Figure 114 Latin America microRNA market estimates and forecasts, 2021-2033 (USD million)
Figure 115 Key country dynamics
Figure 116 Brazil microRNA market estimates and forecasts, 2021-2033 (USD million)
Figure 117 Key country dynamics
Figure 118 Argentina microRNA market estimates and forecasts, 2021-2033 (USD million)
Figure 119 MEA microRNA market estimates and forecasts, 2021-2033 (USD million)
Figure 120 Key country dynamics
Figure 121 South Africa microRNA market estimates and forecasts, 2021-2033 (USD million)
Figure 122 Key country dynamics
Figure 123 Saudi Arabia microRNA market estimates and forecasts, 2021-2033 (USD million)
Figure 124 Key country dynamics
Figure 125 UAE microRNA market estimates and forecasts, 2021-2033 (USD million)
Figure 126 Key country dynamics
Figure 127 Kuwait microRNA market estimates and forecasts, 2021-2033 (USD million)
Companies Mentioned
The key companies profiled in this MicroRNA market report include:- Thermo Fisher Scientific, Inc.
- QIAGEN
- Horizon Discovery Group plc.
- NanoString Technologies, Inc.
- Merck KGaA
- Takara Bio, Inc.
- LGC Limited
- BioGenex
- GeneCopoeia, Inc.
- New England Biolabs
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 120 |
| Published | November 2025 |
| Forecast Period | 2024 - 2033 |
| Estimated Market Value ( USD | $ 1.76 Billion |
| Forecasted Market Value ( USD | $ 5.48 Billion |
| Compound Annual Growth Rate | 13.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |
